BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17729388)

  • 1. Should nonalcoholic fatty liver disease be regarded as a hepatic illness only?
    Tarantino G
    World J Gastroenterol; 2007 Sep; 13(35):4669-72. PubMed ID: 17729388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and nonalcoholic fatty liver disease.
    Angulo P
    Nutr Rev; 2007 Jun; 65(6 Pt 2):S57-63. PubMed ID: 17605315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.
    Dietrich P; Hellerbrand C
    Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):637-53. PubMed ID: 25194181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease and the metabolic syndrome.
    Marchesini G; Marzocchi R; Agostini F; Bugianesi E
    Curr Opin Lipidol; 2005 Aug; 16(4):421-7. PubMed ID: 15990591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Future of Nonalcoholic Fatty Liver Disease Treatment.
    Mazhar K
    Med Clin North Am; 2019 Jan; 103(1):57-69. PubMed ID: 30466676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
    Hamaguchi M; Kojima T; Takeda N; Nakagawa T; Taniguchi H; Fujii K; Omatsu T; Nakajima T; Sarui H; Shimazaki M; Kato T; Okuda J; Ida K
    Ann Intern Med; 2005 Nov; 143(10):722-8. PubMed ID: 16287793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome and non-alcoholic fatty liver disease.
    Almeda-Valdés P; Cuevas-Ramos D; Aguilar-Salinas CA
    Ann Hepatol; 2009; 8 Suppl 1():S18-24. PubMed ID: 19381120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic Fatty Liver Disease in Children: Hepatic and Extrahepatic Complications.
    Selvakumar PKC; Kabbany MN; Nobili V; Alkhouri N
    Pediatr Clin North Am; 2017 Jun; 64(3):659-675. PubMed ID: 28502444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of inflammation in nonalcoholic steatohepatitis.
    Choi S; Diehl AM
    Curr Opin Gastroenterol; 2005 Nov; 21(6):702-7. PubMed ID: 16220049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol and Obesity: A Dangerous Association for Fatty Liver Disease.
    Mahli A; Hellerbrand C
    Dig Dis; 2016; 34 Suppl 1():32-9. PubMed ID: 27548267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
    Boppidi H; Daram SR
    Postgrad Med; 2008 Jul; 120(2):E01-7. PubMed ID: 18654060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease and the epidemic of obesity.
    Collantes R; Ong JP; Younossi ZM
    Cleve Clin J Med; 2004 Aug; 71(8):657-64. PubMed ID: 15449761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
    Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
    World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GI epidemiology: nonalcoholic fatty liver disease.
    Angulo P
    Aliment Pharmacol Ther; 2007 Apr; 25(8):883-9. PubMed ID: 17402991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease burden - Saudi Arabia and United Arab Emirates, 2017-2030.
    Alswat K; Aljumah AA; Sanai FM; Abaalkhail F; Alghamdi M; Al Hamoudi WK; Al Khathlan A; Al Quraishi H; Al Rifai A; Al Zaabi M; Babatin MA; Estes C; Hashim A; Razavi H
    Saudi J Gastroenterol; 2018; 24(4):211-219. PubMed ID: 29956688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action.
    Bril F; Cusi K
    Diabetes Care; 2017 Mar; 40(3):419-430. PubMed ID: 28223446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty liver and the metabolic syndrome.
    Neuschwander-Tetri BA
    Curr Opin Gastroenterol; 2007 Mar; 23(2):193-8. PubMed ID: 17268250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease as a feature of the metabolic syndrome.
    Socha P; Wierzbicka A; Neuhoff-Murawska J; Włodarek D; Podleśny J; Socha J
    Rocz Panstw Zakl Hig; 2007; 58(1):129-37. PubMed ID: 17711101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease.
    Baranova A; Tran TP; Birerdinc A; Younossi ZM
    Aliment Pharmacol Ther; 2011 Apr; 33(7):801-14. PubMed ID: 21251033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiological survey of prevalence of fatty liver and its risk factors in a general adult population of Shanghai].
    Fang JG; Zhu J; Li XJ; Li R; Dai F; Song XM; Chen L; Li F; Chen SY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):83-8. PubMed ID: 15727689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.